Why the study?
Cardiovascular disease remains the leading cause of death worldwide, and the intricate relationship between inflammation and natural myocardial regeneration warrants further investigation.
This review highlights a paradigm shift in cardiac cell therapy, suggesting that innate inflammatory responses and paracrine signaling, rather than direct cellular engraftment, mediate the functional improvements seen in clinical trials.
Cardiovascular disease remains the leading cause of death worldwide despite significant advances in our understanding of the disease and its treatment. Consequently, the therapeutic potential of cell therapy and induction of natural myocardial regeneration have stimulated a recent surge of research and clinical trials aimed at addressing this challenge. Recent developments in the field have shed new light on the intricate relationship between inflammation and natural regeneration, an intersection that warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Elde et al. (2021) conducted a review in Ischemic heart disease. Cell therapy and paracrine signaling was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: